Thrombocytopenia in patients with severe acute respiratory syndrome (review)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Hematology

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10245330400026170PMID 16019455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and Laboratory Features of Severe Acute Respiratory Syndrome Vis-À-Vis Onset of Fever

  2004cited by this paper
• Clinical Description of a Completed Outbreak of SARS in Vietnam, February–May, 2003

  2004cited by this paper
• Aetiology: Koch's postulates fulfilled for SARS virus

  2003cited by this paper
• The Genome Sequence of the SARS-Associated Coronavirus

  2003cited by this paper
• Effects of Oxygen-Induced Lung Damage on Megakaryocytopoiesis and Platelet Homeostasis in a Rat Model

  2003cited by this paper
• Aminopeptidase N inhibitors and SARS

  2003cited by this paper
• A cluster of cases of severe acute respiratory syndrome in Hong Kong.

  2003cited by this paper
• Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

  2003cited by this paper
• Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome.

  2003cited by this paper
• A novel coronavirus associated with severe acute respiratory syndrome.

  2003cited by this paper
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

  2003cited by this paper
• Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases

  2003cited by this paper
• Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

  2003cited by this paper
• Measurement of subgroups of peripheral blood T lymphocytes in patients with severe acute respiratory syndrome and its clinical significance.

  2003cited by this paper
• Identification of severe acute respiratory syndrome in Canada.

  2003cited by this paper
• Severe acute respiratory syndrome in a medical center in Taipei.

  2003cited by this paper
• Clinical presentations and outcome of severe acute respiratory syndrome in children

  2003cited by this paper
• Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong

  2003cited by this paper
• A major outbreak of severe acute respiratory syndrome in Hong Kong.

  2003influential reference
• Glucocorticoids and acute lung injury

  2003cited by this paper
• Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

  2003cited by this paper
• Lymphopenia in SARS

  2003cited by this paper
• Coronavirus as a possible cause of severe acute respiratory syndrome

  2003influential reference
• In Vitro Detection of Apoptosis in Monocytes/Macrophages Infected with Human Coronavirus

  2002cited by this paper
• HIV-related thrombocytopenia.

  2002cited by this paper
• Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 Entry*

  2002cited by this paper
• Molecular Determinants of Species Specificity in the Coronavirus Receptor Aminopeptidase N (CD13): Influence of N-Linked Glycosylation

  2001cited by this paper
• Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia.

  2001cited by this paper
• Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression.

  2000cited by this paper
• The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

  1999cited by this paper
• Identification of PDGF Receptors on Human Megakaryocytes and Megakaryocytic Cell Lines

  1997cited by this paper
• Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice.

  1995cited by this paper
• Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction.

  1994cited by this paper
• Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.

  1994cited by this paper
• HIV-related thrombocytopenia.

  1992cited by this paper
• Human aminopeptidase N is a receptor for human coronavirus 229E

  1992cited by this paper
• Protein disulfide isomerase. A multifunctional protein resident in the lumen of the endoplasmic reticulum.

  1992cited by this paper
• Prednisone-induced alterations of circulating human lymphocyte subsets.

  1983cited by this paper
• Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease.

  1983influential reference
• Corticosteroid‐Mediated Immunoregulation in Man

  1982cited by this paper

• Comparison of the Prevalence of Thrombocytopenia in Deceased and Recovered COVID-19 Patients Admitted to the ICU of Imam Khomeini Hospital, Ardabil

  2025cites this paper
• PATHOLOGICAL PARAMETERS HELPFUL IN SCREENING AND STRATIFICATION OF COVID-19 PATIENTS

  2025cites this paper
• The Effect of COVID‐19 on Platelet Counts in Persistent and Chronic Adult ITP Patients: A Real‐World Study in China

  2025cites this paper
• Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety

  2025cites this paper
• LABORATORY INDICES OF COAGULATION AND INFLAMMATION IN PATIENTS WITH CORONAVIRUS INFECTION

  2025cites this paper
• Comparison of changes in blood group, hemogram and biochemical parameters in healthcare workers with and without COVID-19

  2025cites this paper
• Comparison of Platelet Indices, Lymphocyte, and Systemic Inflammation Indices on Days 1 and 8 in Surviving and Non-Surviving COVID-19 Patients at Hasan Sadikin General Hospital, Bandung, Indonesia

  2025cites this paper
• To determine the mean NLR(Neutrophil Lymphocyte Ratio) and Mean PLR(Platelet Lymphocyte Ratio) in Covid-19 patients

  2025cites this paper
• Terapi thrombopoietin receptor agonist pada pasien immune thrombocytopenia dengan infeksi COVID-19: sebuah laporan kasus

  2024cites this paper
• Assessing the impact of severe acute respiratory syndrome coronavirus 2 infection on hematological parameters.

  2024cites this paper
• Viruses and thrombocytopenia

  2024influential citation
• The effect of vitamin D deficiency on platelet parameters in patients with COVID-19

  2024cites this paper
• Neutropenia and SARS-CoV-2 infection, A review of the literature.

  2024cites this paper
• Biogenesis aberration: One of the mechanisms of thrombocytopenia in COVID-19

  2023cites this paper
• The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination

  2023cites this paper
• CORRELATION OF COVID-19 SEVERITY with HEMATOLOGICAL, BIOCHEMICAL, COAGULA-TION AND INFLAMMATORY MARKERS- A CROSS-SECTIONAL STUDY

  2023cites this paper
• Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimization

  2023cites this paper
• Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination.

  2023cites this paper
• Alterações bioquímicas de pacientes com COVID-19

  2023cites this paper
• Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children

  2023cites this paper
• Current knowledge of thrombocytopenia in sepsis and COVID-19

  2023cites this paper
• An Overview of Remdesivir and Aspirin Treatment in COVID-19

  2023cites this paper
• Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities

  2023cites this paper
• The Effect of SARS-COV-2 Infection on the Hematological Markers

  2023cites this paper
• Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence

  2023cites this paper
• The aggregate index of systemic inflammation may predict mortality in COVID-19 patients with chronic renal failure.

  2023cites this paper
• A study on the effect of aspirin on clinical symptoms, laboratory indices, and outcomes in patients with COVID-19

  2023cites this paper
• A lab-on-chip solution for the detection and suppression of COVID-19 severity

  2023cites this paper
• Review on the Biogenesis of Platelets in Lungs and Its Alterations in SARS-CoV-2 Infection Patients

  2023cites this paper
• Hyperinflammatory Response in COVID-19: A Systematic Review

  2023cites this paper
• Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review

  2022cites this paper
• Frequency of thrombocytopenia in severe COVID-19 pneumonia and its effects on clinical outcomes.

  2022influential citation
• Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review

  2022cites this paper
• High Mean Platelet Volume and Mean Platelet Volume/Platelet Ratio Predict Mortality for COVID-19 Patients in Intensive Care Unit

  2022cites this paper
• The Role of Vascular-Platelet Hemostasis Disturbances in the Genesis of Respiratory Failure in Patients with COVID-19

  2022cites this paper
• Hematological manifestations of COVID-19 acute respiratory distress syndrome patients and the impact of thrombocytopenia on disease outcomes: A retrospective study

  2022cites this paper
• Estimation of Thrombocytopenia in Patients of COVID-19 in a Tertiary Care Centre as a Prognostic marker

  2022cites this paper
• Clinical and radiological characteristics of adult hospitalized coronavirus disease-2019 patients of Dhaka, Bangladesh

  2022cites this paper
• Hematological Changes in the Second Wave of SARS-CoV-2 in North India

  2022cites this paper
• Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature

  2022cites this paper
• COVID-19 and Multiorgan Dysfunction Syndrome

  2022cites this paper
• Hematopoietic responses to SARS-CoV-2 infection

  2022cites this paper
• Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients

  2022cites this paper
• Clinical and laboratory predictors of poor outcome COVID-19 in routine practice

  2022cites this paper
• Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines

  2022cites this paper
• Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?

  2022cites this paper
• Prognostic factors for predicting severity and mortality in hospitalized COVID‐19 patients

  2022cites this paper
• Risks of emergency vascular surgery in COVID-19 patients

  2021cites this paper
• Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients

  2021cites this paper
• Management challenges in patients with comorbid COVID-19 associated delirium and serious mental illness – A case series

  2021cites this paper
• Hematological manifestations and complications of COVID-19.

  2021cites this paper
• CANPT Score: A Tool to Predict Severe COVID-19 on Admission

  2021cites this paper
• Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19

  2021cites this paper
• Impact of SARS-CoV-2 on the clinical outcomes and placental pathology of pregnant women and their infants: A systematic review

  2021influential citation
• Clinical features and viral RNA shedding of imported and local cases with COVID-19 in Wenzhou, China

  2021cites this paper
• Emerging Roles of Coronavirus in Autoimmune Diseases

  2021cites this paper
• Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective

  2021cites this paper
• Variations in Haematological and Immunological Parameters Among Hospitalized COVID-19 Patients

  2021cites this paper
• COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management

  2021cites this paper
• The interplay between the immune system and SARS-CoV-2 in COVID-19 patients

  2021cites this paper
• Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study

  2021cites this paper
• Hematological Parameters in Pregnant Women with COVID-19: A Systematic Review

  2021cites this paper
• Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps

  2021cites this paper
• A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms

  2021cites this paper
• Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

  2021cites this paper
• Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19

  2021cites this paper
• COVID-19 induced immune thrombocytopenic purpura: case report.

  2021cites this paper
• Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

  2021cites this paper
• Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients

  2021cites this paper
• Autoimmune complications of COVID‐19

  2021cites this paper
• Adaptive Immunity and the Risk of Autoreactivity in COVID-19

  2021cites this paper
• Management of COVID-19-related immune thrombocytopenia by rhTPO

  2021cites this paper
• 12 Mrinalini Singh.cdr

  2021cites this paper
• The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines

  2021cites this paper
• Interaction of the inflammatory response and megakaryocytes in COVID-19 infection

  2021cites this paper
• Idiopathic Thrombocytopenic Purpura in Post COVID-19 Condition: Case Study

  2021cites this paper
• ENGINEERING MATHEMATICAL MODELLING OF CORONA VIRUS (COVID-19) TRANSMISSION IN IRAQ

  2021cites this paper
• Optimal Triage for COVID-19 Patients Under Limited Intensive Care Unit Capacity: Development of a Parsimonious Machine Learning Prediction Model and Threshold Optimization Using Discrete-Event Simulation

  2021cites this paper
• Blood Cells Indices are Determinants of the COVID-19 Outcome: A Cross-Sectional Study from ‎Kurdistan Region-Iraq

  2021cites this paper
• Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling

  2021cites this paper
• Can laboratory tests at the time of admission guide us to the prognosis of patients with COVID-19?

  2021cites this paper
• Prevalence and characteristics of malaria among COVID-19 individuals: A systematic review, meta-analysis, and analysis of case reports

  2021cites this paper
• Optimal Triage for COVID-19 Patients Under Limited Health Care Resources With a Parsimonious Machine Learning Prediction Model and Threshold Optimization Using Discrete-Event Simulation: Development Study

  2021cites this paper
• Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review

  2021cites this paper
• Meta-analysis of coagulation disbalances in COVID-19: 41 studies and 17601 patients

  2021cites this paper
• Can Hemogram Parameters Predict a Positive PCR Result in COVID-19?

  2021cites this paper
• COVID-19 and Multiorgan Dysfunction Syndrome

  2021cites this paper
• The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19

  2021cites this paper
• Anticoagulation in COVID-19: a review of current literature and guidelines

  2021cites this paper
• The outcome of COVID-19 in patients with hematological malignancy

  2021cites this paper
• Platelet Dysregulation in the Pathobiology of COVID-19

  2021cites this paper
• Prothrombotic Phenotype in COVID-19: Focus on Platelets

  2021cites this paper
• Epidemiology and Etiopathogeny of COVID-19.

  2021cites this paper
• TITLE: Post-Mortem Findings in Italian Patients with Covid-19 – a Descriptive Full Autopsy Study of cases with and without co-morbidities.

  2021cites this paper
• Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?

  2021cites this paper
• Clinical, laboratory, and radiological features indicative of novel coronavirus disease (COVID‐19) in emergency departments: a multicenter case‐control study in Hong Kong

  2020influential citation
• SARS-CoV-2-Induced Severe Immune Thrombocytopenic Purpura

  2020cites this paper
• Thrombocytopenia in the Course of COVID-19 Infection

  2020cites this paper
• Green Synthesis of Copper Nanoparticles Using Aqueous Solution of Flowers of Capparis Decidua from Cholistan Desert

  2020cites this paper
• A case report and summary of thrombocytopenia caused by coronavirus disease 2019

  2020cites this paper